Azelaprag

CAS No. 2049980-18-7

Azelaprag( —— )

Catalog No. M33277 CAS No. 2049980-18-7

Azelaprag (AMG 986) is an effective small-molecule apelin receptor agonist. Azelaprag can be used to treat neurological diseases and cardiovascular diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 602 In Stock
5MG 1121 In Stock
10MG 1454 In Stock
25MG 1987 In Stock
50MG 2576 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Azelaprag
  • Note
    Research use only, not for human use.
  • Brief Description
    Azelaprag (AMG 986) is an effective small-molecule apelin receptor agonist. Azelaprag can be used to treat neurological diseases and cardiovascular diseases.
  • Description
    Azelaprag (Example 263.0) is an apelin receptor agonist agent candidate.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Apelin receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2049980-18-7
  • Formula Weight
    523.61
  • Molecular Formula
    C25H29N7O4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 5 mg/mL (9.55 mM; Ultrasonic )
  • SMILES
    N(S([C@H]([C@H](C)C=1N=CC(C)=CN1)C)(=O)=O)C=2N(C(=NN2)C=3C=C(C)C=NC3)C4=C(OC)C=CC=C4OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. WO2016187308A1.
molnova catalog
related products
  • 1-Oleoyl-rac-glycero...

    1-O-Oleyl-rac-glycerol also known as monoolein is a surfactant that releases free glycerol and oleic acid upon hydrolysis.

  • MRT-81

    MRT-81 inhibits human and rodent smoothened?Smo?receptors effectively with an IC50?value of 41 nM in the Shh-light2 cells. MRT-81 has potent hedgehog inhibiting activity. MRT-81 also can be used for the research of cancer.

  • Vorapaxar sulfate

    Vorapaxar sulfate is a potent and orally active thrombin receptor (PAR-1) antagonist.